Avanzanite Bio Secures €32M Series A Investment from MVM Partners
18 Nov 2025 //
BUSINESSWIRE
Avanzanite Partner Agio Receives Positive Opinion for Pyrukynd
17 Oct 2025 //
PHARMIWEB
Avanzanite Appoints General Manager To Expand Italian Operations
14 Oct 2025 //
PHARMIWEB
Dr. Mark Joins Avanzanite Bioscience as SVP Medical Affairs
10 Sep 2025 //
BUSINESSWIRE
Avanzanite partners Agios to launch Pyrukynd in Europe
09 Jun 2025 //
BUSINESSWIRE
Avanzanite Bioscience Appoints Sotiris Botozis as GM South Europe
10 Apr 2025 //
BUSINESSWIRE
Avanzanite Bioscience Appoints Chief Financial Officer
03 Feb 2025 //
BUSINESSWIRE
EC Authorizes Avanzanite Bioscience`s Orphan Drug AKANTIOR
27 Aug 2024 //
BUSINESSWIRE
Avanzanite`s AKANTIOR Gets CHMP Opinion, Expands To 26 EU Countries
03 Jun 2024 //
BUSINESSWIRE
Avanzanite Expands Partnership With Advicenne in Additional European Countries
18 Oct 2023 //
BUSINESSWIRE
Avanzanite Further Strengthens Leadership Team With Country Manager of Germany
19 Sep 2023 //
BUSINESSWIRE
Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal
28 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support